HK1006359A1 - Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2, 5-dioxo -imidazoldin-1-yl)acetylamino)-3 -phenylpropionate - Google Patents

Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2, 5-dioxo -imidazoldin-1-yl)acetylamino)-3 -phenylpropionate

Info

Publication number
HK1006359A1
HK1006359A1 HK98105621A HK98105621A HK1006359A1 HK 1006359 A1 HK1006359 A1 HK 1006359A1 HK 98105621 A HK98105621 A HK 98105621A HK 98105621 A HK98105621 A HK 98105621A HK 1006359 A1 HK1006359 A1 HK 1006359A1
Authority
HK
Hong Kong
Prior art keywords
methyl
imidazoldin
phenylpropionate
acetylamino
dioxo
Prior art date
Application number
HK98105621A
Other languages
English (en)
Inventor
Hans Ulrich Stilz
Gerhard Beck
Manfred Radau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HK1006359A1 publication Critical patent/HK1006359A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK98105621A 1996-06-05 1998-06-18 Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2, 5-dioxo -imidazoldin-1-yl)acetylamino)-3 -phenylpropionate HK1006359A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19622489A DE19622489A1 (de) 1996-06-05 1996-06-05 Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters

Publications (1)

Publication Number Publication Date
HK1006359A1 true HK1006359A1 (en) 1999-02-26

Family

ID=7796165

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105621A HK1006359A1 (en) 1996-06-05 1998-06-18 Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2, 5-dioxo -imidazoldin-1-yl)acetylamino)-3 -phenylpropionate

Country Status (24)

Country Link
US (1) US6294562B1 (xx)
EP (1) EP0811616B1 (xx)
JP (1) JP4249277B2 (xx)
KR (1) KR980002029A (xx)
CN (1) CN1104420C (xx)
AR (1) AR008993A1 (xx)
AT (1) ATE294783T1 (xx)
AU (1) AU717106B2 (xx)
BR (1) BR9703459A (xx)
CA (1) CA2206748C (xx)
CZ (1) CZ292672B6 (xx)
DE (2) DE19622489A1 (xx)
ES (1) ES2241016T3 (xx)
HK (1) HK1006359A1 (xx)
HR (1) HRP970309B1 (xx)
HU (1) HUP9700998A3 (xx)
IL (1) IL120984A (xx)
MX (1) MX9704128A (xx)
NO (1) NO307999B1 (xx)
PL (1) PL320355A1 (xx)
RU (1) RU2174119C2 (xx)
SK (1) SK70897A3 (xx)
TR (1) TR199700457A2 (xx)
ZA (1) ZA974912B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
MXPA06003661A (es) * 2003-10-02 2006-06-05 Pharmacia & Upjohn Co Llc Sales y polimorfos de un compuesto de indolinona sustituido con pirrol.
ES2400772T3 (es) * 2005-06-07 2013-04-12 Ramot At Tel Aviv University Ltd. Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas
KR20090048462A (ko) 2006-07-17 2009-05-13 라모트 앳 텔-아비브 유니버시티 리미티드 통증완화용 ｇａｂａ 접합체
EP2252578B1 (en) 2008-02-11 2012-08-01 Ramot at Tel Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
EP2509603A1 (en) 2009-12-09 2012-10-17 Biolinerx Ltd. Methods of improving cognitive functions
WO2011104637A2 (en) 2010-02-24 2011-09-01 Ramot At Tel-Aviv University Ltd. Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
WO2019200202A1 (en) 2018-04-12 2019-10-17 Morphic Therapeutic, Inc. Antagonists of human integrin (alpha4)(beta7)
JP7437490B2 (ja) 2019-10-16 2024-02-22 モーフィック セラピューティック，インコーポレイテッド ヒトインテグリン（アルファ－４）（ベータ－７）の阻害

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) 1992-07-24 1994-01-27 Cassella Ag Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4308034A1 (de) 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4309867A1 (de) 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
DE19515177A1 (de) * 1995-04-28 1996-10-31 Cassella Ag Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
IL120984A (en) 2001-08-26
HU9700998D0 (en) 1997-07-28
CZ292672B6 (cs) 2003-11-12
BR9703459A (pt) 1998-10-06
AU2467497A (en) 1997-12-11
ES2241016T3 (es) 2005-10-16
KR980002029A (ko) 1998-03-30
DE59712294D1 (de) 2005-06-09
NO307999B1 (no) 2000-07-03
CA2206748C (en) 2007-05-01
ATE294783T1 (de) 2005-05-15
AU717106B2 (en) 2000-03-16
HUP9700998A1 (hu) 1998-03-30
HRP970309B1 (en) 2002-06-30
ZA974912B (en) 1997-12-05
CN1104420C (zh) 2003-04-02
EP0811616A1 (de) 1997-12-10
DE19622489A1 (de) 1997-12-11
SK70897A3 (en) 1999-05-07
AR008993A1 (es) 2000-03-08
CN1174835A (zh) 1998-03-04
HRP970309A2 (en) 1998-04-30
US6294562B1 (en) 2001-09-25
CZ172997A3 (en) 1997-12-17
NO972506L (no) 1997-12-08
CA2206748A1 (en) 1997-12-05
HUP9700998A3 (en) 1999-03-01
TR199700457A2 (xx) 1997-12-21
RU2174119C2 (ru) 2001-09-27
NO972506D0 (no) 1997-06-02
JPH1059948A (ja) 1998-03-03
EP0811616B1 (de) 2005-05-04
IL120984A0 (en) 1997-11-20
MX9704128A (es) 1997-12-31
PL320355A1 (en) 1997-12-08
JP4249277B2 (ja) 2009-04-02

Similar Documents

Publication Publication Date Title
PL326498A1 (en) D-winian(-)cis-6(s)-phenyl-5(r)-[4-(pyrolydin-1-ylethoxy)phenyl]5,6,7,8-tetrahydronaphtalen-2-ol
AU656344B2 (en) N-(4-(5-(cyclopentyloxycarbonyl)-amino-1-methyl-indol- 3-ylmethyl)-3 methoxybenzoyl)-2-methylbenzene-sulphonamide
AU3435697A (en) N-(4-(Heteroarylmethyl)Phenyl)-Heteroarylamines
AP9700976A0 (en) Mesylate dihydrate salts of 5- (2- (4- (1,2- benzisothiazol-3-YL)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
AU7177296A (en) Crystalline hydrochloride of (R)-(-)-2-N-(4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl)- aminomethyl-chroman
HK1006359A1 (en) Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2, 5-dioxo -imidazoldin-1-yl)acetylamino)-3 -phenylpropionate
NZ307479A (en) A process for preparing 4-(4-halo substituted phenyl)-3-(3,4-methylenedioxy phenoxy methyl)piperidine derivatives
ZA965998B (en) 2-(4-Substituted)-benzylamino-2-methyl-propanamide derivatives
IL128505A (en) Process for the preparation of (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy) phenyl]-3-methoxypropenoate
NZ299788A (en) 4-substituted(4-(1-adamantyl)phenyl) derivatives
IL148273A0 (en) Glucopyranoside conijugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
HK1061843A1 (en) Process for cis-1-(2-(4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronape ethyl) pyrrolidine
AU4436296A (en) 6-{triazolyl{3-(trifluoromethyl)phenyl}methyl}-2- quinolinones and -quinolinethiones
HK1042484B (zh) 製備(R)-α-(2，3-二甲氧基苯基)-1-[2-(4-氟苯基)乙基]-4-哌啶甲醇的方法
NO20006350D0 (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
AU2267897A (en) 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
HUP9800511A3 (en) Phosphorylized derivatives of 4-{4-[4-(hydroxy-diphenyl)-1-pipe
AU7247096A (en) Methods and compositions for controlling biofouling using n-alkyl heterocyclic compounds
SI1095035T1 (sl) Postopek za pripravo 4-(3-piridinil)-1H-imidazola in uporabljeni intermediati
NZ301453A (en) 4-(substituted phenyl),4-(substituted carboxyl, carboxylamide or alkyl)-cyclohexan-1-one derivatives and medicaments
EP0699675A3 (en) 3- (4- (1-Substituted-4-piperazinyl) butyl) -4-thiazolidinone and related compounds
AU7647998A (en) Substituted 4-(3-alkenyl-benzoyl)-pyrazoles
ZA989842B (en) Esters of (+)-Ó-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol.
HK1019328A1 (en) 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
HUP0202145A3 (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070603